Infectious Disease Research

Emerging Pathogens
Bacteriology Program

The scientific focus of the bacteriology program is on public health and biodefense. Testing of BSL-2 and BSL-3 pathogens is provided for both government and commercial clients and can be conducted in compliance with the FDA Good Laboratory Practice (GLP) regulations.

Capabilities:

• Assay Development
• Antimicrobial Susceptibility Testing
• Minimum Inhibitory Concentration (MIC)
• Minimum Bactericidal Concentration (MBC)
• Low/High-Throughput Drug Screening
• Customized Screening Panels
• In vitro Macrophage Models
• Animal Model Development

Pathogens:

• Threat Agents
• Bacillus anthracis
• Francisella tularensis
• Yersinia pestis
• Mycobacterium tuberculosis
• Multi-Drug Resistant Tuberculosis (MDR-TB)
• Clinically Relevant Drug Sensitive/Drug Resistant Strains of Infection